Auro Laboratories Ltd Financials
Company Logo

Auro Laboratories Ltd Financial Statement

Auro Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
Revenue3.19
Operating Expense2.74
Net Profit-0.11
Net Profit Margin-3.45
Earning Per Share-0.17
EBIDTA0.44
Effective Tax RateTBA

Auro Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual19.40
Operating Expenses Annual16.00
Operating Profit Annual4.06
Interest Annual1.08
Depreciation1.10
Net Profit Annual1.84
Tax Annual0.04

Auro Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning1.65
Cash Flow from Operations5.75
Cash Flow from Investing-24.45
Cash Flow from Financing17.69
Cash Flow at the End0.63

Auro Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)20.93
PBIT Margin (%)15.26
PBT Margin (%)1.14
Net PROFIT Margin (%)9.48
Return On Networth / Equity (%)4.33
Return On Networth /Employed (%)3.79
Return On Assets (%)2.37
Total Debt / Equity (X)0.81
Asset Turnover Ratio (%)0.25

Auro Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual21.06
Total Current Assets Annual21.51
Non Current Assets Annual77.58
Total Shareholders Funds Annual42.97
Total Assets Annual99.10

Auro Laboratories Ltd Earning Calls

No Data Availabe

FAQS on Auro Laboratories Ltd Financials

As of Oct 4, 2025, Auro Laboratories Ltd has a market capitalization of 143.69 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Auro Laboratories Ltd is not with a debt-to-equity ratio of 1.05.

In FY 2024 , Auro Laboratories Ltd recorded a total revenue of approximately 19.40 Cr marking a significant milestone in the company's financial performance.

Auro Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.7% and -0.5% annually, respectively..

Auro Laboratories Ltd's current PE ratio is 78.09.

Auro Laboratories Ltd's ROCE averaged 10.0% from the FY ending March 2023 to 2025, with a median of 10.5%. It peaked at 16.2% in March 2024, reflecting strong capital efficiency over the period..

Auro Laboratories Ltd's latest EBIT is Rs. 2.96 Cr, surpassing the average EBIT of Rs. 6.10 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions